Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study
Main Authors: | Sandra Wagner, Marie Metzger, Martin Flamant, Pascal Houillier, Jean-Philippe Haymann, François Vrtovsnik, Eric Thervet, Jean-Jacques Boffa, Ziad A. Massy, Bénédicte Stengel, Patrick Rossignol, for the NephroTest Study group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | BMC Nephrology |
Online Access: | http://link.springer.com/article/10.1186/s12882-017-0723-2 |
Similar Items
-
Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study
by: Sandra Wagner, et al.
Published: (2017-09-01) -
The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease.
by: Lucile Mercadal, et al.
Published: (2014-01-01) -
Decrease in urinary creatinine excretion in early stage chronic kidney disease.
by: Elena Tynkevich, et al.
Published: (2014-01-01) -
Low Serum Creatine Kinase Level Predicts Mortality in Patients with a Chronic Kidney Disease.
by: Adrien Flahault, et al.
Published: (2016-01-01) -
Renal function can improve at any stage of chronic kidney disease.
by: Lise Weis, et al.
Published: (2013-01-01)